62 results on '"Cuervas‐Mons, V"'
Search Results
2. Inmunosupresión en el trasplante hepático
3. Management of multidrug resistant Gram-negative bacilli infections in solid organ transplant recipients: SET/GESITRA-SEIMC/REIPI recommendations
4. Rapid liver fibrosis regression after sustained virological response in HCV patients treated with direct acting antivirals
5. The presence of two or more baseline NS5A resistance associated substitutions jeopardizes DAA treatment success in HCV patients
6. Drug-Induced Lung Injury in a Liver Transplant Patient Treated With Sofosbuvir
7. Safety and Efficacy of Sofosbuvir plus Simeprevir in a Spanish Cohort of 622 Cirrhotic Patients Infected with Genotypes 1 or 4
8. Results of Radiofrequency Ablation in a Cohort of Cirrhotic Patients at Liver Transplantation
9. Sofosbuvir and Simeprevir Therapy for Recurrent Hepatitis C Genotype 1, after Liver Transplantation: Efficacy and Safety
10. Rapid Changes in Cholesterol in Chronic Hepatitis C Patients Treated with Antivirals and Potential Impacton Cardiovascular Risk
11. Ledipasvir/Sofosbuvir for Recurrent Hepatitis C in Liver Transplant Recipients: A Real-Life Spanish Multicentre Experience
12. Efficacy and Clinical Impact of Daclatasvir-Based Antiviral Therapy in Severe Recurrent Hepatitis C after Liver Transplantation. Results from a Multicenter Spanish Group
13. Mucosal leishmaniasis mimicking squamous cell carcinoma in a liver transplant recipient
14. P0040 : Long-term cardiovascular mortality after liver transplantation: Analysis of risk factors
15. TT Genotype of Transforming Growth Factor Beta1 +869C/T Is Associated With the Development of Chronic Kidney Disease After Liver Transplantation
16. Long-Term Survivors After Pediatric Liver Transplatation Are at Increased Risk for Development of Cardiovascular Disease Events: Analysis of 30 Cases
17. CC Genotype at rs12979860 of IL28B Is Associated With Lower Risk of New-onset Diabetes After Transplantation in Adult Patients With Liver Transplantation for Hepatitis C Cirrhosis
18. P908 EVEROLIMUS TREATMENT IN LIVER TRANSPLANTATION ACCORDING TO CLINICAL PRACTICE: A SPANISH MULTICENTRE COHORT
19. Toll-like Receptor 3 L412F Polymorphism May Protect Against Acute Graft Rejection in Adult Patients Undergoing Liver Transplantation for Hepatitis C-Related Cirrhosis
20. Influence of Infection by Aspergillus in Arterial Complications After Liver Transplantation: Evolution and Results in 670 Transplants
21. Hepatitis C Virus Sensitivity to Combined Antiviral Therapy in Liver Transplant Versus Immunocompetent Patients
22. Breakthrough Rhinocerebral Mucormycosis in a Liver Transplant Patient Receiving Caspofungin
23. Right Adrenal Metastases of Hepatocarcinoma After Liver Transplantation: Case Report and Literature Review
24. Donor Infection and Transmission to the Recipient of a Solid Allograft
25. Hepatitis C Recurrence After Liver Transplantation: Viral and Histologic Response to Full-Dose Peg-Interferon and Ribavirin
26. Five-Year Follow-up of a Trial Comparing Tacrolimus and Cyclosporine Microemulsion in Liver Transplantation
27. Therapy of Intractable Pruritus With MARS
28. Results of Liver Transplantation in Patients With Previous Portosystemic Shunts
29. Cardiovascular morbidity and obesity in adult liver transplant recipients
30. Effectiveness of low-dose intramuscular Anti-VHB immune globulin in the prophylaxis of viral B hepatitis reinfection after liver transplantation: preliminary report
31. Usefulness of chemotherapy as prophylaxis of tumor recurrence after liver transplantation in advanced hepatocellular carcinomas
32. Effectiveness and safety of mycophenolate mofetil as monotherapy in liver transplantation
33. Chronic renal dysfunction after liver transplantation in adult patients: prevalence, risk factors, and impact on mortality
34. De novo malignancies and liver transplantation
35. Effectiveness and security of mycophenolate mofetil as monotherapy in liver transplantation
36. Influence of immunosuppressive therapy in the incidence of chronic renal failure after liver transplantation
37. Recurrence of primary biliary cirrhosis after liver transplantation
38. De novo malignancies in liver transplantation
39. Usefulness of mycophenolate mofetil in patients with chronic renal insufficiency after liver transplantation
40. Documento de consenso de indicaciones de trasplante hepático
41. Steroid-free regimen with daclizumab, mycophenolate mofetil, and tacrolimus in liver transplant recipients
42. Infección por herpesvirus humano-6 y trasplante de órganos
43. Visceral Leishmaniasis (Kala‐azar) in Solid Organ Transplantation: Report of Five Cases and Review
44. Hepatocellular carcinoma: adjuvant chemotherapy postliver transplant
45. Influence of antiviral therapy on the natural history of hepatitis B virus recurrence after liver transplantation: retrospective study of 14 cases
46. INFLUENCE OF ANTIVIRAL THERAPY IN THE NATURAL HISTORY OF HEPATITIS B VIRUS RECURRENCE AFTER LIVER TRANSPLANTATION: RETROSPECTIVE STUDY OF 14 CASES
47. Late orthotopic liver retransplant: indications and survival
48. Incidence and outcome of De Novo malignancies after liver transplantation
49. Efficacy and safety of oral low-dose tacrolimus treatment in liver transplantation
50. Efficacy and safety of oral low-dose tacrolimus treatment in liver transplantation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.